Dartmouth Health is the only health care system on the East Coast to be part of the newly launched Brain Health Navigator ...

Older studies estimated a lower risk of dementia. According to new research, the number of people living with the disease in ...

Alzheimer's disease begins with a long period during which abnormal amyloid and tau proteins build up in the brain without ...

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

A new study found a link between a common type of herpes virus and Alzheimer's disease. Experts explain the finding—but there ...

Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

Groundbreaking research reveals potential link between cytomegalovirus (CMV) and Alzheimer's disease, offering new insights ...

The Davos Alzheimer’s Collaborative (DAC), a pioneering worldwide initiative seeking to cure Alzheimer’s disease and improve ...

Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer’s-related psychosis during the ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Activation of SIGMAR1 is expected to restore cellular homeostasis by inducing autophagy, which may slow neurodegeneration in patients with early AD.